Hello and Welcome to Patientsville.com, Your Source for all MANNITOL information. We are dedicated to provide You with MANNITOL safety information. Learn about MANNITOL serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MANNITOL Safety Reports
Total MANNITOL reports: 15.MANNITOL FDA safety alerts: No.
Reported deaths: 1 .
Take MANNITOL Side Effects Survey or Share Your MANNITOL Story. Read More Here.
Physician from UNITED STATES reported MANNITOL problem on Oct 13, 2006. Male patient, 64 years of age, weighting 141.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant neoplasm progression, thrombocytopenia, tumour lysis syndrome. MANNITOL dosage: 2.5 MG, OTHER. During the same period patient was treated with GEMZAR, CISPLATIN, DEXAMETHASONE. Patient died on 10/19/2006.
MANNITOL problem was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2007. Female patient, 54 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 57 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
MANNITOL problem was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 65 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Health Professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: macular oedema, maculopathy, visual disturbance. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
MANNITOL problem was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 66 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: macular oedema, maculopathy, visual acuity reduced. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Health Professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 73 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
MANNITOL problem was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 34 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 73 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 34 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 54 years of age, was diagnosed with central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 57 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: blood brain barrier defect, central nervous system lymphoma, maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 65 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy, visual disturbance. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.